Understanding Semaglutide: A GLP-1 Receptor Agonist Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist (a medication that mimics a natural hormone regulating blood sugar and appetite)
Adults taking the 2.4 mg weekly injection, combined with lifestyle intervention, typically lost an average of 15% to 17% of their body weight over approximately 68 weeks
This technology can vastly improve user compliance by simplifying the number of factors the user must track. Accurate temperature sensing is also of utmost importance because many biologics require cold chain storage
A novel role for a glycosylphosphatidylinositol-anchored aspartyl protease, CgYps1, in the regulation of pH homeostasis in Candida glabrata
Patches, Creams, and Nasal Sprays : These methods are considered to have varying absorption abilities
NEJM Rosenstock, J., et al